Margaret Humphries

1.8k citations

15 papers · 1.3k indexed · h-index 10

Genetics top 2%
- Virus-based gene therapy research 10
Ophthalmology top 5%
- Retinal Diseases and Treatments 2
Molecular Biology top 10%
- Viral Infectious Diseases and Gene Expression in Insects 5
- Retinal Development and Disorders 3
- RNA Interference and Gene Delivery 2
Oncology top 10%
Infectious Diseases top 10%
Epidemiology
- Herpesvirus Infections and Treatments 4
Electrical and Electronic Engineering
- Energy Harvesting in Wireless Networks 1
Health, Toxicology and Mutagenesis
- Air Quality and Health Impacts 1

Co-authors: Terence R. Flotte Jeffrey D. Chulay Mark Brantly Roberto Calcedo Barry J. Byrne L. Terry Spencer Farshid N. Rouhani James M. Wilson
Cited by: Genetics Ophthalmology Molecular Biology
Journals: Proceedings of the National Academy of Sciences (1 paper)Ophthalmology (1 paper)Investigative Ophthalmology & Visual Science (1 paper)
Partner nations: United States Ireland United Kingdom

In The Last Decade

Margaret Humphries

13 papers receiving 1.3k citations

Peers

Countries citing papers authored by Margaret Humphries

Since Specialization

Citations

This map shows the geographic impact of Margaret Humphries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Humphries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Humphries more than expected).

Fields of papers citing papers by Margaret Humphries

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Humphries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Humphries. The network helps show where Margaret Humphries may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Margaret Humphries, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Margaret Humphries Line = papers co-authored together Margaret Humphries links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	Results at 5 Years After Gene Therapy for RPE65-Deficient Retinal Dystrophy Human Gene Therapy ·Mark E. Pennesi,Richard G. Weleber,Paul Yang,Chris Whitebirch,Beverly Thean,Terence R. Flotte,Margaret Humphries,Elvira N. Chegarnov,Kathleen N. Beasley,J. Timothy Stout,Jeffrey D. Chulay	2018	50
2	5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency Molecular Therapy ·Christian Mueller,Gwladys Gernoux,Alisha M. Gruntman,Florie Borel,Emer P. Reeves,Roberto Calcedo,Farshid N. Rouhani,Anthony T. Yachnis,Margaret Humphries,Martha Campbell‐Thompson,Louis M. Messina,Jeffrey D. Chulay,Bruce C. Trapnell,James M. Wilson,Noel G. McElvaney,Terence R. Flotte	2017	82
3	Results at 2 Years after Gene Therapy for RPE65-Deficient Leber Congenital Amaurosis and Severe Early-Childhood–Onset Retinal Dystrophy Ophthalmology ·Richard G. Weleber,Mark E. Pennesi,David J. Wilson,Shalesh Kaushal,Laura Erker,Lauren Jensen,Maureen T. McBride,Terence R. Flotte,Margaret Humphries,Roberto Calcedo,William W. Hauswirth,Jeffrey D. Chulay,J. Timothy Stout	2016	160
4	24. Sustained Expression with Partial Correction of Neutrophil Defects 5 Years After Intramuscular rAAV1 Gene Therapy for Alpha-1 Antitrypsin Deficiency Molecular Therapy ·Christian Mueller,Jeffrey D. Chulay,Noel G. McElvaney,Gwladys Gernoux,Emer P. Reeves,Farshid N. Rouhani,Margaret Humphries,Alisha M. Gruntman,Martha Campbell‐Thompson,James M. Wilson,Terence R. Flotte	2016	2
5	Treatment of Patients with Leber Congenital Amaurosis Type 2 with an AAV Vector Expressing RPE65 Investigative Ophthalmology & Visual Science ·Tim Stout,Richard G. Weleber,Maureen T. McBride,David J. Wilson,Dawn Peters,Margaret Humphries,Terence R. Flotte,Lauren Jensen,Andreas Lauer,Jeffrey D. Chulay	2013	1
6	Phase 2 Clinical Trial of a Recombinant Adeno-Associated Viral Vector Expressing α ₁ -Antitrypsin: Interim Results Human Gene Therapy ·Terence R. Flotte,Bruce C. Trapnell,Margaret Humphries,Brenna Carey,Roberto Calcedo,Farshid N. Rouhani,Martha Campbell‐Thompson,Anthony T. Yachnis,Robert A. Sandhaus,Noel G. McElvaney,Christian Mueller,Louis M. Messina,James M. Wilson,Mark Brantly,David R. Knop,Guo-jie Ye,Jeffrey D. Chulay	2011	265
7	Phase 2 Clinical Trial Of A Recombinant Adeno-Associated Virus (RAAV) Alpha-1 Antitrypsin (AAT) Gene Therapy Vector Terence R. Flotte,Bruce Trapnell,Margaret Humphries,Brenna Carey,Roberto Calcedo,Martha Campbell‐Thompson,Farshid N. Rouhani,Anthony T. Yachnis,Robert A. Sandhaus,Noel G. McElvaney,Mark Brantly,James M. Wilson,Jeffrey D. Chulay	2011	0
8	Preclinical Evaluation of a Recombinant Adeno-Associated Virus Vector Expressing Human Alpha-1 Antitrypsin Made Using a Recombinant Herpes Simplex Virus Production Method Human Gene Therapy ·Jeffrey D. Chulay,Guo-jie Ye,Darby L. Thomas,David R. Knop,Janet M. Benson,Julie A. Hutt,Gensheng Wang,Margaret Humphries,Terence R. Flotte	2010	48
9	Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy Proceedings of the National Academy of Sciences ·Mark Brantly,Jeffrey D. Chulay,Lili Wang,Christian Mueller,Margaret Humphries,L. Terry Spencer,Farshid N. Rouhani,Thomas J. Conlon,Roberto Calcedo,Michael R. Betts,Carolyn Spencer,Barry J. Byrne,James M. Wilson,Terence R. Flotte	2009	257
10	Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Serotype 2 α 1-Antitrypsin (AAT) Vector in AAT-Deficient Adults Human Gene Therapy ·Mark Brantly,L. Terry Spencer,Margaret Humphries,Thomas J. Conlon,Carolyn T. Spencer,Amy Poirier,Wendy Garlington,Dawn J. Baker,Sihong Song,Kenneth I. Berns,Nicholas Muzyczka,Richard O. Snyder,Barry J. Byrne,Terence R. Flotte	2006	141
11	Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Alpha 1-Antitrypsin (rAAV2-CB-hAAT) Gene Vector to AAT-Deficient Adults Human Gene Therapy ·Terence R. Flotte,Mark Brantly,L. Terry Spencer,Barry J. Byrne,Carolyn T. Spencer,Dawn J. Baker,Margaret Humphries	2004	112
12	Phase I Trial of Intranasal and Endobronchial Administration of a Recombinant Adeno-Associated Virus Serotype 2 (rAAV2)-CFTR Vector in Adult Cystic Fibrosis Patients: A Two-Part Clinical Study Human Gene Therapy ·Terence R. Flotte,Pamela L. Zeitlin,Thomas C. Reynolds,Alison E. Heald,Patty Pedersen,Suzanne E. Beck,C. Conrad,Lois Brass‐Ernst,Margaret Humphries,Kevin Sullivan,Randall C. Wetzel,G R Taylor,Barrie J. Carter,William B. Guggino	2003	180
13	A Phase I Study of AAV-CFTR Administration in Adult Cystic Fibrosis Patients 1794 Pediatric Research ·Terence R. Flotte,Pamela L. Zeitlin,Richard Daifuku,Sandra Afione,Erik M. Schwiebert,Sharon Allen,Suzanne E. Beck,Thomas Reynolds,Mary Wagner,Lois Brass‐Ernst,Greenberry Taylor,Randall C. Wetzel,Kevin Sullivan,Sandra Friborg,Margaret Humphries,Kye Chesnut,S. R. Goodwin,Beryl J. Rosenstein,B. J. Carter,William B. Guggino	1997	1
14	PARTICIPATION, COMPLEXITY OF UNDERSTANDING, AND THE ASSESSMENT OF ORGANIZATIONAL CHANGE. Academy of Management Proceedings ·Jean M. Bartunek,Danna Greenberg,Margaret Humphries,Barbara Parmer Davidson	1996	3
15	ABSORPTION OF LEAD AND CARBON MONOXIDE IN SYDNEY TRAFFIC POLICEMEN The Medical Journal of Australia ·J. A. Bisby,K. H. Ouw,Margaret Humphries,A. Shandar	1977	12

About Margaret Humphries

Margaret Humphries is a scholar working on Genetics, Ophthalmology and Epidemiology, having authored 15 papers that have together received 1.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (10 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers), Herpesvirus Infections and Treatments (4 papers), Retinal Development and Disorders (3 papers), RNA Interference and Gene Delivery (2 papers), Retinal Diseases and Treatments (2 papers), Energy Harvesting in Wireless Networks (1 paper) and Air Quality and Health Impacts (1 paper). The work is most often cited by research in Genetics (863 citations), Ophthalmology (128 citations) and Molecular Biology (893 citations). Margaret Humphries has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include Terence R. Flotte, Jeffrey D. Chulay, Mark Brantly, Roberto Calcedo, Barry J. Byrne, L. Terry Spencer, Farshid N. Rouhani, James M. Wilson, Christian Mueller and Thomas J. Conlon. Their work appears in journals such as Proceedings of the National Academy of Sciences, Ophthalmology and Investigative Ophthalmology & Visual Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact